Dendrite International, Inc., a provider of pharmaceutical industry solutions, has recently announced that Schering Corporation, has signed a five-year agreement to enhance VISION, its sales force effectiveness (SFE) and business planning solution, for its U.S.-based pharmaceutical field sales organization.
TMCnet
Simplifying Global Compliance
Recommended Products
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological Risk Evaluation and Management for Medical Devices
Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.
Editor's Picks
Biom’up’s Laparoscopic Applicator Earns New Marketing Approval
The device quickly delivers Hemoblast powder to bleeding areas in minimally-invasive surgeries.
Lawmakers Want Probe of BMS/Celgene Deal
The cancer drugs the company will acquire as part of the deal include Celgene’s blockbuster drug Revlimid.
FDAnews Drug Daily Bulletin
DENDRITE PARTNERS WITH SCHERING-PLOUGH
July 6, 2006
